Gold Standard Diagnostics’ Next-Generation Lyme Disease Testing Becoming Widely Accepted Amongst Clinical Laboratories

Achieve Accurate, Reproducible Results with FDA Cleared Borrelia burgdorferi B31 Confirmation Blots

DAVIS, Calif.--()--Gold Standard Diagnostics, Corp. (GSD, www.gsdx.us), a leading manufacturer and marketer of clinical laboratory instrumentation and assays for the in vitro diagnostics market, announces new Line Immunoassay technology for Lyme confirmation testing. GSD gives clinical laboratories an FDA cleared, improved option for serological confirmation testing for Lyme disease according to the CDC-recommended two-step process. Both the IgG and IgM line blots are substantially equivalent to traditional Western Blot technology, but offer advancements in usability and objectivity through use of Line Immunoassay technology. GSD’s LIA test strips offer numerous enhancements including: improved sensitivity and specificity, consistent results, large lot sizes, easier handling and automation options.

“The demands of today’s clinical laboratories require consistent, reliable and user-friendly products said,” John Griffiths, CEO of Gold Standard Diagnostics. Gold Standard’s innovative quality products, automation options, and excellent service meet those needs. The advanced technology of the GSD Lyme LIA can improve test results, workflow efficiency and cost effectiveness for these clinical laboratories.”

Differentiating Features of Line Blots

  • Easy to handle – Nitrocellulose backed and individually numbered strips make handling easy and fool proof.
  • Easy to read – Clear bands for each antigen, a serum control band and a cutoff control band make it easy to interpret each sample result. Additionally, strips can be scanned and interpreted by GSD software.
  • Clinically significant antigens – 10 IgG antigens match CDC requirements for testing for general infection as well as determination of the stage of infection. All 3 IgM proteins are included for early and disseminated Lyme disease diagnosis.
  • Strips are affixed in a booklet of durable materials allowing for easy handling. The unique numbering system makes working with GSD’s Lyme line blots simple regardless of testing volume. Whether the blots are run manually or on a fully-automated processor/reader system, the enhanced durability and easy of handling make GSD’s line blots the Lyme confirmation test of choice for laboratories large and small.

For more information on Lyme disease visit our website: http://www.gsdx.us/lyme

Simplify Your Laboratory Experience

Contact Gold Standard Diagnostics for more information:

Email: info@gsdx.us | Phone: (530) 759-8000 | Web: http://www.gsdx.us/

About Gold Standard Diagnostics:

Gold Standard Diagnostics (GSD) provides comprehensive diagnostic solutions that improve lab efficiency and minimize overall costs. Through an extensive product menu, automated instrument platforms, and outstanding customer service, GSD solves real laboratory problems. The result is a seamless laboratory experience achieved through an integrated approach.

More information is available at http://www.gsdx.us/

Contacts

For Gold Standard Diagnostics
Cheryl Cink, 530.219.3949
ccink@syncpr.com

Release Summary

Gold Standard Diagnostics’ Next-Generation Lyme Disease Testing Becoming Widely Accepted Among Clinical Laboratories Achieve Accurate, Reproducible Results with FDA Cleared Borrelia burgdorferi B3

Contacts

For Gold Standard Diagnostics
Cheryl Cink, 530.219.3949
ccink@syncpr.com